#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2738	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2389	272.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1565	1565	C	344	C,A,T	327,3,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2738	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2389	272.5	0	HET	.	.	.	C207T,A	.	207	207	C	588	588	C	264	C,T,A	126,107,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2738	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2389	272.5	0	HET	.	.	.	C451T,A,G	.	451	451	C	832	832	C	336	C,T,A,G	216,94,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4862	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4038	298.3	0	.	n	.	0	T695C	SNP	695	695	T	1230	1230	C	408	C,G,T,A	387,3,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4862	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4038	298.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	2173	2173	G	341	G,A,C,T	179,150,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4862	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4038	298.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2506	2506	C	311	C,G,A,T	295,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4862	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4038	298.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2580	2580	A	313	A,G,C,T	288,3,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4862	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4038	298.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3132	3132	C	376	C,A,T	363,2,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	344	folP	855	855	100.0	folP.l6.c4.ctg.1	1948	43.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1242	1244	AGC	38;38;38	A;G;C	37;37;36	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	666	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3762	43.6	1	SNP	p	S91F	1	.	.	271	273	TTC	717	719	TTC	48;48;48	T;T;C	44;44;46	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	666	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3762	43.6	1	SNP	p	D95G	1	.	.	283	285	GGC	729	731	GGC	48;49;49	G;G;C	46;48;48	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	666	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3762	43.6	1	SNP	p	G95N	0	.	.	283	285	GGC	729	731	GGC	48;49;49	G;G;C	46;48;48	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	306	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1827	41.5	1	SNP	p	G45D	0	.	.	133	135	GGC	721	723	GGC	72;73;73	G;G;C	65;63;67	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	174	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1560	27.2	0	.	n	.	0	A197.	DEL	197	197	A	886	886	A	60	A	58	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	758	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	51.7	1	SNP	p	D86N	0	.	.	256	258	GAC	887	889	GAC	52;48;55	G;A;C	43;38;45	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	758	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	51.7	1	SNP	p	R87I	0	.	.	259	261	CGT	890	892	CGT	55;55;55	C;G;T,G	50;41;47,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	758	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	51.7	1	SNP	p	S87R	1	.	.	259	261	CGT	890	892	CGT	55;55;55	C;G;T,G	50;41;47,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	758	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	51.7	1	SNP	p	R87W	0	.	.	259	261	CGT	890	892	CGT	55;55;55	C;G;T,G	50;41;47,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	758	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	51.7	1	SNP	p	S88P	0	.	.	262	264	TCC	893	895	TCC	55;55;55	T;C,G;C	49;49,1;52	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	584	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3255	44.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1884	1886	GGC	45;46;46	G;G;C	42;41;41	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	548	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2722	49.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1566	1568	GCC	45;47;47	G,C;C;C,T	43,1;47;46,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	548	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2722	49.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1569	1571	ATG	47;47;47	A;T;G	47;47;47	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	548	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2722	49.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1581	1583	ACC	50;50;50	A;C;C	49;49;50	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	548	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2722	49.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1581	1583	ACC	50;50;50	A;C;C	49;49;50	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	548	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2722	49.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2082	2084	ACC	78;76;76	A;C,G;C	70;63,1;68	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	548	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2722	49.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2136	2138	GCG	75;74;74	G,T,C;C,G;G,T,A	61,1,1;58,1;60,1,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	548	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2722	49.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2136	2138	GCG	75;74;74	G,T,C;C,G;G,T,A	61,1,1;58,1;60,1,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	548	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2722	49.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2259	2261	GGT	50;50;49	G,T;G,C;T,G	49,1;47,1;47,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	548	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2722	49.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2268	2270	AGC	43;43;43	A,T,C;G;C,T,A	33,1,1;37;34,1,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	548	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2722	49.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2286	2288	CCG	36;36;36	C,G;C;G	30,1;28;32	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	922	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3550	63.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1837	1839	CCG	75;75;74	C;C,A;G,C,A,T	63;67,1;58,2,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	402	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2367	42.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	852	852	C	38	C	37	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	420	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2388	43.5	1	SNP	p	G120K	1	.	.	358	360	AAG	1013	1015	AAG	71;71;71	A,C;A;G,C	68,1;68;63,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	420	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2388	43.5	1	SNP	p	N121D	0	.	.	361	363	AAC	1016	1018	AAC	71;71;70	A;A;C,A	66;70;64,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	420	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2388	43.5	1	SNP	p	A121N	1	.	.	361	363	AAC	1016	1018	AAC	71;71;70	A;A;C,A	66;70;64,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1430	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5423	65.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	160	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1450	27.4	1	SNP	p	V57M	1	.	.	169	171	ATG	789	791	ATG	50;49;49	A;T;G	49;49;49	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
